Search research articles
Contact Us
Filters
Showing results (291-300 of 372) with videos related to
Page
of 38
Sort By:
Ebiomedicine
|
September 11, 2022
Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8<sup>+</sup> T cells
Hiroshi Takata, Juyeon C Kakazu, Julie L Mitchell, et al.
The Journal of Infectious Diseases
|
August 30, 2014
Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses
Genevieve G Fouda, Coleen K Cunningham, Elizabeth J McFarland, et al.
The Journal of Infectious Diseases
|
October 3, 2017
Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost
Julie A Ake, Alexandra Schuetz, Poonam Pegu, et al.
Journal of Virology
|
November 29, 2019
Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and Potency
David Easterhoff, Justin Pollara, Kan Luo, et al.
Journal of Virology
|
October 27, 2021
Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques
Jingyou Yu, Natalie D Collins, Noe B Mercado, et al.
Cell
|
November 19, 2013
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys
Dan H Barouch, Kathryn E Stephenson, Erica N Borducchi, et al.
Plos Pathogens
|
September 4, 2020
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge
Kier Om, Dominic Paquin-Proulx, Maria Montero, et al.
Cells
|
August 25, 2019
Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection
Sodsai Tovanabutra, Rujipas Sirijatuphat, Phuc T Pham, et al.
The Lancet. Infectious Diseases
|
June 30, 2023
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial
Michael A Koren, Leyi Lin, Kenneth H Eckels, et al.
Mbio
|
August 29, 2025
First-generation N-terminal domain supersite public antibodies retain activity against Omicron-derived lineages and protect mice against Omicron BA.5 challenge
Vincent Dussupt, Jaime L Jensen, Paul V Thomas, et al.
Page
of 38
Search research articles
Search
Showing results (291-300 of 372) with videos related to
Sort By:
Page
of 38
Ebiomedicine
|
September 11, 2022
Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8<sup>+</sup> T cells
Hiroshi Takata, Juyeon C Kakazu, Julie L Mitchell, et al.
The Journal of Infectious Diseases
|
August 30, 2014
Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses
Genevieve G Fouda, Coleen K Cunningham, Elizabeth J McFarland, et al.
The Journal of Infectious Diseases
|
October 3, 2017
Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost
Julie A Ake, Alexandra Schuetz, Poonam Pegu, et al.
Journal of Virology
|
November 29, 2019
Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and Potency
David Easterhoff, Justin Pollara, Kan Luo, et al.
Journal of Virology
|
October 27, 2021
Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques
Jingyou Yu, Natalie D Collins, Noe B Mercado, et al.
Cell
|
November 19, 2013
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys
Dan H Barouch, Kathryn E Stephenson, Erica N Borducchi, et al.
Plos Pathogens
|
September 4, 2020
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge
Kier Om, Dominic Paquin-Proulx, Maria Montero, et al.
Cells
|
August 25, 2019
Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection
Sodsai Tovanabutra, Rujipas Sirijatuphat, Phuc T Pham, et al.
The Lancet. Infectious Diseases
|
June 30, 2023
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial
Michael A Koren, Leyi Lin, Kenneth H Eckels, et al.
Mbio
|
August 29, 2025
First-generation N-terminal domain supersite public antibodies retain activity against Omicron-derived lineages and protect mice against Omicron BA.5 challenge
Vincent Dussupt, Jaime L Jensen, Paul V Thomas, et al.
Page
of 38